Abstract:Purpose/Objective(s) Plasma ctHPVDNA is detectable prior to treatment in ∼90% of patients with HPV-OPSCC and has shown utility in the dynamic monitoring of treatment response and detecting recurrences (4, 5, 6). Recent data has demonstrated ctHPVDNA to be detectable in patients with sinonasal and nasopharyngeal primary tumors (7). Herein, we present our early experience of ctHPVDNA detection in non-oropharyngeal HPV-associated head and neck cancers using an ultrasensitive multianalyte droplet polymerase chain reaction assay that tests for cell free tumor tissue modified viral (TTMV)-HPV DNA (liquid biopsies). Materials/Methods The medical record of all head and neck cancer patients at our institution seen from April 2022-September 1, 2023 were reviewed. HPV status was determined by immunohistochemical staining of tumor tissue for p16 and in-situ hybridization for high risk subtypes of HPV, per our institutional standard procedures. TTMV-HPV DNA results, patient demographic information, clinical data, and were obtained from chart review. Results We identified 20 patients with non-oropharyngeal HPV-associated head and neck cancers in whom TTMV-HPV DNA was assessed. All cancers were p16 positive and HPV was tested in 8/20 and was positive in 7/8. Of these 20 patients, 15 patients had assessment TTMV-HPV DNA prior to treatment. This included 3 patients with SCC of the nasopharynx, 3 patients with sinonasal SCC, 1 patient with SCC of the posterior pharyngeal wall, 3 patients with SCC of unknown primary, 1 patient with SCC of the oral tongue, 2 patients with SCC of the larynx, 1 patient with cutaneous SCC, and one patient with sinonasal neuroendocrine carcinoma of the ethmoid sinus. Pre-treatment TTMV-HPV DNA was detectable in 13/16 with a median value of 7,808 (range 0-98,950). 11 had TTMV-HPV16 DNA positivity, 1 -HPV18, 0-HPV 33, 1 -HPV 35. TTMV-HPV DNA was undetectable in patients with the following primary sites: T4N0 subglottic SCCA (HPV positive), and pT2N0 SCC of the nasal cavity (HPV positive). Conclusion Circulating TTMV-HPV DNA is detectable in non-oropharyngal HPV-associated head and neck cancers. More research is needed to validate the sensitivity, specificity, and clinical utility of TTMV-HPV DNA in non-oropharyngeal HPV-associated head and neck cancers.

The landscape of circulating tumor HPV DNA and TTMV-HPVDNA for surveillance of HPV-oropharyngeal carcinoma: systematic review and meta-analysis

The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors

Circulating HPV Tumor DNA and Molecular Residual Disease in HPV-Positive Oropharyngeal Cancers: A Scoping Review

Mapping the research landscape of HPV-positive oropharyngeal cancer: a bibliometric analysis

Circulating tumor HPV DNA in the management of HPV+ oropharyngeal cancer and its correlation with MRI

Circulating Tumor HPV DNA for Surveillance of HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Narrative Review

Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancer

Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance

DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW

Narrative Review on the Current Evidence in the Literature

HPV Detection Methods in Head and Neck Cancer

Navigating the landscape of HPV-associated cancers: From epidemiology to prevention

HPV-associated head and neck cancer: a virus-related cancer epidemic

Detectable Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA in Non-Oropharyngeal Head and Neck Cancers

A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The "ALARM" study

HPV and head and neck cancers: Towards early diagnosis and prevention

Human papillomavirus circulating tumor DNA assays as a mechanism for head and neck cancer equity in rural regions of the United States

Human Papillomavirus Oral Infection: Review of Methodological Aspects and Epidemiology

The evolution of the epidemiological landscape of head and neck cancer in Italy: Is there evidence for an increase in the incidence of potentially HPV-related carcinomas?

Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study

Oral and periodontal manifestation related during human papilloma virus infections: Update on early prognostic factors